Investor Relations
Einleitung mit Text, Video und Listing

Investor Relations Our aim is to strengthen Siegfried‘s standing and credibility in the public and to enhance long-term enterprise value. As our focus is on transparency, we disclose all relevant information to facilitate comprehensive assessment of the company.

siegfried_Investor_Relations.jpg
Text mit Border

There are many good reasons to invest in Siegfried:

  • Siegfried is a leading global Custom Development and Manufacturing Organization (CDMO), with Net Sales of CHF 845m and approximately 3'550 employees worldwide
  • Siegfried's integrated offering covers development and manufacturing in both Drug Substances (Active Pharmaceutical Ingredients) as well as Drug Products (Finished Dosage Forms)
  • The CDMO market offers attractive growth dynamics: low cyclicality, low volatility, resilient growth and high structural profitability
  • The pharmaceutical industry is changing, leading to favorable trends for the CDMO market
  • It is Siegfried's ambition to consistently deliver robust growth and execute on value accretive M&A to outgrow market and competitors
Text

The Siegfried Group cultivates an open and ongoing communication with its customers, employees and investors as well as with the media and the interested public. Priority is given to timely provision of information concerning business activities.

Mitarbeiter
placeholder

Siegfried AG
Miriam Anton
Head Corporate Communications
Untere Bruehlstrasse 4
4800 Zofingen
Switzerland

Phone +41 62 746 12 71
Mobile +41 79 366 32 73
miriam.anton@siegfried.ch

placeholder

Siegfried AG
Reto Suter
CFO
Untere Bruehlstrasse 4
4800 Zofingen
Switzerland

Phone +41 62 746 11 35
reto.suter@siegfried.ch